Security · CUSIP 98386D406
XTL BIOPHARMACEUTICALS LTD SPONSORED ADS
COMMON STOCK · institutional ownership from 13F filings
13F holders
3
Shares held
7.6K
Value held
$20.7K
New / sold out
1 / 4
Added / reduced
1 / 1
net -65.1K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| RHUMBLINE ADVISERS | 6,228 | $17.0K | 0.00% |
| GAMMA Investing LLC | 1,213 | $3.3K | 0.00% |
| UBS Group AG | 125 | $341 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| RHUMBLINE ADVISERS | Added | +241 | +4.0% |
| UBS Group AG | New | +125 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Noked Israel Ltd | Sold out | -49,722 | -100.0% |
| SmartHarvest Portfolios, LLC | Sold out | -13,351 | -100.0% |
| GAMMA Investing LLC | Reduced | -2,175 | -64.2% |
| Tower Research Capital LLC (TRC) | Sold out | -244 | -100.0% |
| MORGAN STANLEY | Sold out | -10 | -100.0% |